Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-06-12 @ 4:19 PM
Study NCT ID:
NCT01231802
Status:
UNKNOWN
Last Update Posted:
2012-07-17
First Post:
2010-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
Sponsor:
Adherex Technologies, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AHX-03-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Gray Kirby/Clinical Project Manager
Old Organization:
Adherex Technologies, Inc.